173 related articles for article (PubMed ID: 28117675)
21. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
[TBL] [Abstract][Full Text] [Related]
22. TANK Binding Kinase 1 Promotes BACH1 Degradation through Both Phosphorylation-Dependent and -Independent Mechanisms without Relying on Heme and FBXO22.
Liu L; Matsumoto M; Watanabe-Matsui M; Nakagawa T; Nagasawa Y; Pang J; Callens BKK; Muto A; Ochiai K; Takekawa H; Alam M; Nishizawa H; Shirouzu M; Shima H; Nakayama K; Igarashi K
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673728
[TBL] [Abstract][Full Text] [Related]
23. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis.
Suzuki N; Johmura Y; Wang TW; Migita T; Wu W; Noguchi R; Yamaguchi K; Furukawa Y; Nakamura S; Miyoshi I; Yoshimori T; Ohta T; Nakanishi M
Autophagy; 2021 Nov; 17(11):3776-3793. PubMed ID: 33706682
[TBL] [Abstract][Full Text] [Related]
24. FBXO22 degrades nuclear PTEN to promote tumorigenesis.
Ge MK; Zhang N; Xia L; Zhang C; Dong SS; Li ZM; Ji Y; Zheng MH; Sun J; Chen GQ; Shen SM
Nat Commun; 2020 Apr; 11(1):1720. PubMed ID: 32249768
[TBL] [Abstract][Full Text] [Related]
25. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
Zhou X; Jin W; Jia H; Yan J; Zhang G
J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
[TBL] [Abstract][Full Text] [Related]
26. Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis.
Liu P; Cong X; Liao S; Jia X; Wang X; Dai W; Zhai L; Zhao L; Ji J; Ni D; Liu Z; Chen Y; Pan L; Liu W; Zhang J; Huang M; Liu B; Tan M
Cell Death Differ; 2022 Jan; 29(1):1-13. PubMed ID: 34215846
[TBL] [Abstract][Full Text] [Related]
27. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation.
Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells.
Chen J; Pan Y; He B; Ying H; Wang F; Sun H; Deng Q; Liu X; Lin K; Peng H; Cho WC; Wang S
Int J Oncol; 2015 Oct; 47(4):1476-84. PubMed ID: 26316167
[TBL] [Abstract][Full Text] [Related]
29. Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation.
Huang W; Luo WJ; Zhu P; Tang J; Yu XL; Cui HY; Wang B; Zhang Y; Jiang JL; Chen ZN
Biochem J; 2013 Jan; 449(2):437-48. PubMed ID: 23005037
[TBL] [Abstract][Full Text] [Related]
30. Host F-Box Protein 22 Enhances the Uptake of Brucella by Macrophages and Drives a Sustained Release of Proinflammatory Cytokines through Degradation of the Anti-Inflammatory Effector Proteins of Brucella.
Mazumdar V; Joshi K; Nandi BR; Namani S; Gupta VK; Radhakrishnan G
Infect Immun; 2022 May; 90(5):e0006022. PubMed ID: 35420446
[TBL] [Abstract][Full Text] [Related]
31. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
33. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.
Abedini MR; Muller EJ; Bergeron R; Gray DA; Tsang BK
Oncogene; 2010 Jan; 29(1):11-25. PubMed ID: 19802016
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy.
Wu B; Cui J; Yang XM; Liu ZY; Song F; Li L; Jiang JL; Chen ZN
Cell Death Dis; 2017 Jul; 8(7):e2925. PubMed ID: 28703811
[TBL] [Abstract][Full Text] [Related]
35. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
36. Emerging role of FBXO22 in carcinogenesis.
Cheng J; Lin M; Chu M; Gong L; Bi Y; Zhao Y
Cell Death Discov; 2020; 6():66. PubMed ID: 32793396
[TBL] [Abstract][Full Text] [Related]
37. Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
Jia L; Wei W; Cao J; Xu H; Miao X; Zhang J
Ann Hematol; 2009 Aug; 88(8):753-60. PubMed ID: 19125248
[TBL] [Abstract][Full Text] [Related]
38. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion.
Kuang YH; Chen X; Su J; Wu LS; Liao LQ; Li D; Chen ZS; Kanekura T
Cancer Lett; 2009 Apr; 276(2):189-95. PubMed ID: 19097686
[TBL] [Abstract][Full Text] [Related]
39. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
Ma Y; Li X; Cheng S; Wei W; Li Y
Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
